GAMIDA CELL LTD's ticker is GMDA and the CUSIP is M47364100. A total of 57 filers reported holding GAMIDA CELL LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,300 | -46.6% | 10,000 | 0.0% | 0.01% | -36.4% |
| Q2 2023 | $19,300 | +138.3% | 10,000 | 0.0% | 0.01% | +120.0% |
| Q1 2023 | $8,100 | -37.2% | 10,000 | 0.0% | 0.01% | -37.5% |
| Q4 2022 | $12,900 | -19.4% | 10,000 | 0.0% | 0.01% | -33.3% |
| Q3 2022 | $16,000 | -11.1% | 10,000 | 0.0% | 0.01% | 0.0% |
| Q2 2022 | $18,000 | -57.1% | 10,000 | 0.0% | 0.01% | -45.5% |
| Q1 2022 | $42,000 | +68.0% | 10,000 | 0.0% | 0.02% | +83.3% |
| Q4 2021 | $25,000 | -35.9% | 10,000 | 0.0% | 0.01% | -40.0% |
| Q3 2021 | $39,000 | -39.1% | 10,000 | 0.0% | 0.02% | -39.4% |
| Q2 2021 | $64,000 | -60.5% | 10,000 | -50.0% | 0.03% | -29.8% |
| Q1 2021 | $162,000 | +92.9% | 20,000 | +100.0% | 0.05% | -2.1% |
| Q4 2020 | $84,000 | +100.0% | 10,000 | 0.0% | 0.05% | +54.8% |
| Q3 2020 | $42,000 | – | 10,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,858,558 | $18,323,000 | 2.20% |
| Stonepine Capital Management, LLC | 443,507 | $2,843,000 | 1.49% |
| Healthcare Value Capital, LLC | 75,000 | $481,000 | 0.96% |
| Laird Norton Wetherby Trust Company, LLC | 529,103 | $3,391,000 | 0.35% |
| Rock Springs Capital Management LP | 2,107,000 | $13,506,000 | 0.27% |
| FIRST MIDWEST BANK TRUST DIVISION | 276,724 | $1,774,000 | 0.24% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 107,000 | $682,000 | 0.18% |
| Platform Technology Partners | 45,375 | $291,000 | 0.12% |
| PREMIER ASSET MANAGEMENT LLC | 110,660 | $709,000 | 0.10% |
| Virtus ETF Advisers LLC | 34,842 | $223,000 | 0.09% |